Search research articles
Contact Us
Filters
Showing results (1051-1060 of 1,257) with videos related to
Page
of 126
Sort By:
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
December 1, 2011
Interlaboratory study comparison of the 15-day intact adult male rat screening assay: evaluation of an antithyroid chemical and a negative control chemical
Richard A Becker, Don R Bergfelt, Susan Borghoff, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Endocrine Connections
|
March 9, 2026
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK
Thomas van Sloten, Steven H J Hageman, Jan Westerink, et al.
Angewandte Chemie (International Ed. in English)
|
January 2, 2024
Deep Characterisation of the sn-Isomer Lipidome Using High-Throughput Data-Independent Acquisition and Ozone-Induced Dissociation
Jesse A Michael, Reuben S E Young, Rachelle Balez, et al.
The American Journal of Medicine
|
July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial
Daniel H Solomon, M Elaine Husni, Peter A Libby, et al.
American Heart Journal
|
April 29, 2006
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial
Matthews Chacko, A Michael Lincoff, Katherine E Wolski, et al.
Frontiers in Public Health
|
October 28, 2022
Systematic review of the scientific evidence of the pulmonary carcinogenicity of talc
Heather N Lynch, Daniel J Lauer, William J Thompson, et al.
Journal of Cardiology
|
December 2, 2017
Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis
Xiaofang Zeng, A Michael Lincoff, Stefanie Schulz-Schüpke, et al.
Clinical Imaging
|
May 15, 2023
Limited ability of the renal ablation-specific (MC)2 risk scoring system to predict major adverse events from percutaneous renal microwave ablation
Cody H Savage, A Michael Devane, Yufeng Li, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 23, 2025
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Amgad Mentias, Neil Keshvani, Milind Y Desai, et al.
Page
of 126
Search research articles
Search
Showing results (1051-1060 of 1,257) with videos related to
Sort By:
Page
of 126
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
December 1, 2011
Interlaboratory study comparison of the 15-day intact adult male rat screening assay: evaluation of an antithyroid chemical and a negative control chemical
Richard A Becker, Don R Bergfelt, Susan Borghoff, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Endocrine Connections
|
March 9, 2026
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK
Thomas van Sloten, Steven H J Hageman, Jan Westerink, et al.
Angewandte Chemie (International Ed. in English)
|
January 2, 2024
Deep Characterisation of the sn-Isomer Lipidome Using High-Throughput Data-Independent Acquisition and Ozone-Induced Dissociation
Jesse A Michael, Reuben S E Young, Rachelle Balez, et al.
The American Journal of Medicine
|
July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial
Daniel H Solomon, M Elaine Husni, Peter A Libby, et al.
American Heart Journal
|
April 29, 2006
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial
Matthews Chacko, A Michael Lincoff, Katherine E Wolski, et al.
Frontiers in Public Health
|
October 28, 2022
Systematic review of the scientific evidence of the pulmonary carcinogenicity of talc
Heather N Lynch, Daniel J Lauer, William J Thompson, et al.
Journal of Cardiology
|
December 2, 2017
Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis
Xiaofang Zeng, A Michael Lincoff, Stefanie Schulz-Schüpke, et al.
Clinical Imaging
|
May 15, 2023
Limited ability of the renal ablation-specific (MC)2 risk scoring system to predict major adverse events from percutaneous renal microwave ablation
Cody H Savage, A Michael Devane, Yufeng Li, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 23, 2025
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Amgad Mentias, Neil Keshvani, Milind Y Desai, et al.
Page
of 126